Sterling Capital Management’s Climb Bio CLYM Stock Holding History
Bought
Maintained
Sold
Other funds holding CLYM
Sterling Capital Management's CLYM Position: Q3 2026 in Review
Sterling Capital Management increased its Climb Bio (CLYM) stake by 103% in Q3 2026, buying an estimated $6.49K and bringing the position to 918 shares worth $10.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2505.
Sterling Capital Management first reported a position in CLYM in Q3 2024 and has held it in 5 quarters since. 128 funds tracked by Wall St. Rank hold CLYM as of Q3 2026.
- Sterling Capital Management held 918 shares of Climb Bio worth $10.5K as of Q3 2026.
- Sterling Capital Management bought 466 Climb Bio shares in Q3 2026, an estimated $6.49K.
- Climb Bio made up ﹤0.01% of Sterling Capital Management's portfolio in Q3 2026, its #2505 holding.
- Sterling Capital Management first reported a position in Climb Bio in Q3 2024 and has held it in 5 quarters since.
- 128 funds tracked by Wall St. Rank held Climb Bio as of Q3 2026.
Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.